Table 1 Baseline patient and lesion characteristics
DM groupNon-DM groupp Value
Patients (n)3654
Vessels (n)3654
Age (years) (range)67 (10) (34 to 80)67 (8) (45 to 78)0.99
Male (n) (%)25 (75%)45 (84%)0.19
Systemic hypertension (n, %)24 (67%)28 (52%)0.33
Hyperlipidaemia (n, %)22 (61%)29 (54%)0.63
Current smoker (n, %)10 (28%)19 (35%)0.23
Family History (n, %)4 (11%)9 (17%)0.55
Previous myocardial infarction (n, %)6 (17%)11 (20%)0.78
Laboratory data
    Total cholesterol (mg/dl)198 (32)206 (33)0.37
    High-density lipoprotein cholesterol (mg/dl)52 (12)52 (15)0.94
    Low-density lipoprotein cholesterol (mg/dl)114 (24)120 (36)0.48
    Triglycerides (mg/dl)155 (94)166 (117)0.70
    Fasting blood glucose (mg/dl)144 (58)101 (26)0.0001
    Glycosylated haemoglobin (%)6.9 (0.8)5.0 (0.3)<0.0001
Treatment of diabetes
    Insulin (n, %)8 (22%)
    Oral hypoglycaemic agents (n, %)23 (64%)
    Dietary therapy alone (n, %)5 (14%)
Target coronary artery
    LAD (n, %)13 (36%)20 (37%)0.99
    LCX (n, %)8 (22%)9 (17%)0.59
    RCA (n, %)15 (42%)25 (46%)0.83
  • Values are mean (SD) when appropriate. DM, type 2 diabetes mellitus; LAD, left anterior descending artery; LCX, left circumflex artery; RCA, right coronary artery. Fisher’s exact test was used for categorical data; unpaired Student t test was used for continuous data between DM and non-DM groups. Values of p<0.05 were considered statistically significant.